Sirtex Deal Elevated With First-Choice Cancer Therapy

Sirtex Deal Elevated With First-Choice Cancer Therapy

Wolfgang von Brauchitsch/Bloomberg

Germany’s Bayer AG, whose drug Nexavar is being tested in combination with Sirtex’s radiation, would be a logical buyer, while large medical-device companies may also be interested, Morningstar Inc. said.